AAAAAA

   
Results: 1-11 |
Results: 11
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995)
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995), European journal of cancer, 32A, 1996, pp. 1
A RANDOMIZED TRIAL COMPARING 2 DOSES OF THE NEW SELECTIVE AROMATASE INHIBITOR ANASTROZOLE (ARIMIDEX) WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
Authors: JONAT W HOWELL A BLOMQVIST C EIERMANN W WINBLAD G TYRRELL C MAURIAC L ROCHE H LUNDGREN S HELLMUND R AZAB M
Citation: W. Jonat et al., A RANDOMIZED TRIAL COMPARING 2 DOSES OF THE NEW SELECTIVE AROMATASE INHIBITOR ANASTROZOLE (ARIMIDEX) WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 32A(3), 1996, pp. 404-412
ANASTROZOLE, A POTENT AND SELECTIVE AROMATASE INHIBITOR, VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - RESULTS OF OVERVIEW ANALYSIS OF 2 PHASE-III TRIALS
Authors: BUZDAR A JONAT W HOWELL A JONES SE BLOMQVIST C VOGEL CL EIERMANN W WOLTER JM AZAB M WEBSTER A PLOURDE PV
Citation: A. Buzdar et al., ANASTROZOLE, A POTENT AND SELECTIVE AROMATASE INHIBITOR, VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - RESULTS OF OVERVIEW ANALYSIS OF 2 PHASE-III TRIALS, Journal of clinical oncology, 14(7), 1996, pp. 2000-2011
ZD1694 - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH SUBSTANTIAL ACTIVITY IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CANCER
Authors: ZALCBERG JR CUNNINGHAM D VANCUTSEM E FRANCOIS E SCHORNAGEL J ADENIS A GREEN M IVESON A AZAB M SEYMOUR I
Citation: Jr. Zalcberg et al., ZD1694 - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH SUBSTANTIAL ACTIVITY IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 716-721
FINAL RESULTS AND SURVIVAL-DATA OF A LARGE RANDOMIZED TRIAL OF ZD1694IN ADVANCED COLORECTAL-CANCER (ACC) CONFIRM COMPARABLE EFFICACY TO 5-FLUOROURACIL PLUS LEUCOVORIN (5FU+LV)
Authors: VANCUTSEM E CUNNINGHAM D ZALCBERG J RATH U OLVER IN KERR D SVENSSON C SEITZ JF MANGA GP HARPER P LOWERY K AZAB M
Citation: E. Vancutsem et al., FINAL RESULTS AND SURVIVAL-DATA OF A LARGE RANDOMIZED TRIAL OF ZD1694IN ADVANCED COLORECTAL-CANCER (ACC) CONFIRM COMPARABLE EFFICACY TO 5-FLUOROURACIL PLUS LEUCOVORIN (5FU+LV), Gastroenterology, 110(4), 1996, pp. 608-608
ZD1694 (TOMUDEX) - A NEW THYMIDYLATE SYNTHASE INHIBITOR WITH ACTIVITYIN COLORECTAL-CANCER
Authors: JACKMAN AL FARRUGIA DC GIBSON W KIMBELL R HARRAP KR STEPHENS TC AZAB M BOYLE FT
Citation: Al. Jackman et al., ZD1694 (TOMUDEX) - A NEW THYMIDYLATE SYNTHASE INHIBITOR WITH ACTIVITYIN COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1277-1282
2 RANDOMIZED TRIALS ESTABLISHING EFFICACY AND TOLERABILITY OF ARIMIDEX (ZD1033) IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER (PABC)
Authors: JONAT W BUZDAR A HOWELL A JONES S BLOMQVIST C VOGEL C EIRMANN W PLOURDE P AZAB M
Citation: W. Jonat et al., 2 RANDOMIZED TRIALS ESTABLISHING EFFICACY AND TOLERABILITY OF ARIMIDEX (ZD1033) IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER (PABC), European journal of cancer, 31A, 1995, pp. 351-351
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
A PHASE IN STUDY OF TOMUDEX IN RELAPSED EPITHELIAL OVARIAN-CANCER
Authors: GORE ME EARL HM CASSIDY J TATTERSALL M MANSI J SEYMOUR L AZAB M
Citation: Me. Gore et al., A PHASE IN STUDY OF TOMUDEX IN RELAPSED EPITHELIAL OVARIAN-CANCER, Annals of oncology, 6(7), 1995, pp. 724-725
TOMUDEX (ZD1694), A NOVEL AND SPECIFIC THYMIDYLATE SYNTHASE INHIBITORHAS PROMISING ACTIVITY IN ADVANCED COLORECTAL-CANCER
Authors: VANCUTSEM E CUNNINGHAM D ZALCBERG J FRANCOIS E SCHORNAGEL JH ADENIS A GREEN M STARKHAMMER H AZAB M
Citation: E. Vancutsem et al., TOMUDEX (ZD1694), A NOVEL AND SPECIFIC THYMIDYLATE SYNTHASE INHIBITORHAS PROMISING ACTIVITY IN ADVANCED COLORECTAL-CANCER, Gastroenterology, 108(4), 1995, pp. 548-548
PHASE-I STUDY OF RETELLIPTINE DIHYDROCHLORIDE (SR-95325-B) USING A SINGLE 2-HOUR INTRAVENOUS-INFUSION SCHEDULE
Authors: KATTAN J DURAND M DROZ JP MAHJOUBI M MARINO JP AZAB M
Citation: J. Kattan et al., PHASE-I STUDY OF RETELLIPTINE DIHYDROCHLORIDE (SR-95325-B) USING A SINGLE 2-HOUR INTRAVENOUS-INFUSION SCHEDULE, American journal of clinical oncology, 17(3), 1994, pp. 242-245
Risultati: 1-11 |